Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients
Clinical trial NCT01003678 · TERMINATED
Trial details
- NCT number
- NCT01003678
- Sponsor
- Roswell Park Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2013-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.